Perrigo Company PLC banner

Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 9.3 USD -1.27% Market Closed
Market Cap: $1.3B

Perrigo Company PLC
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Perrigo Company PLC
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Perrigo Company PLC
NYSE:PRGO
Research & Development
-$101.4m
CAGR 3-Years
6%
CAGR 5-Years
-3%
CAGR 10-Years
6%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Research & Development
-$809.3m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-20%
Iterum Therapeutics PLC
NASDAQ:ITRM
Research & Development
-$4.2m
CAGR 3-Years
36%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Research & Development
-$39.9m
CAGR 3-Years
-34%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
G
GH Research PLC
NASDAQ:GHRS
Research & Development
-$38.7m
CAGR 3-Years
-24%
CAGR 5-Years
-158%
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Research & Development
-€47.1m
CAGR 3-Years
-60%
CAGR 5-Years
-26%
CAGR 10-Years
-7%
No Stocks Found

Perrigo Company PLC
Glance View

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
HIDDEN
Show

See Also

What is Perrigo Company PLC's Research & Development?
Research & Development
-101.4m USD

Based on the financial report for Sep 27, 2025, Perrigo Company PLC's Research & Development amounts to -101.4m USD.

What is Perrigo Company PLC's Research & Development growth rate?
Research & Development CAGR 10Y
6%

Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Perrigo Company PLC have been 6% over the past three years , -3% over the past five years , and 6% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett